XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Loss Per Common Share
6 Months Ended
Sep. 30, 2020
Loss per common share:  
Loss Per Common Share

11. Loss Per Common Share

 

The Company’s basic net loss per share has been computed based on the weighted average number of common shares outstanding during the period. Diluted net loss per share assumes the exercise of all stock options having exercise prices less than the average market price of the common stock during the period using the treasury stock method and is computed by dividing net loss by the weighted average number of common shares and dilutive potential common shares (stock options) outstanding during the period. In periods where losses are reported, the weighted-average number of common shares outstanding excludes potential common shares, because their inclusion would be anti-dilutive.

 

The following is a reconciliation of the number of shares used in the calculation of basic and diluted net loss per share for the three and six month periods ended September 30, 2020 and 2019.

 

    Three Months Ended     Six Months Ended  
    September 30,     September 30,  
    2020     2019     2020     2019  
Net loss   $ (41,970 )   $ (82,787 )   $ (341,640 )   $ (136,973 )
                                 
Shares outstanding:                                
Weighted avg. shares outstanding – basic     2,040,941       2,040,166       2,040,553       2,040,166  
Effect of assumed exercise of dilutive stock options     -       -       -       -  
Weighted avg. shares outstanding – dilutive     2,040,941       2,040,166       2,040,553       2,040,166  
                                 
Loss per common share:                                
Basic   $ (0.02 )   $ (0.04 )   $ (0.17 )   $ (0.07 )
Diluted   $ (0.02 )   $ (0.04 )   $ (0.17 )   $ (0.07 )

 

Due to a net loss for the for the three and six months ended September 30, 2020, the weighted average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive.